Synergistic Antitumor Effects of 177Lu-Octreotide Combined with an ALK Inhibitor in a High-Risk Neuroblastoma Xenograft Model
Article in Clinical Medicine Insights Therapeutics (August 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Clinical Medicine Insights Therapeutics (August 2024)
Article in Clinical Nuclear Medicine (May 2024)
Article in PET Clinics (April 2024)